ArticleESC heart failure2022

The PARADISE-MI trial: a new opportunity to improve the left ventricular remodelling in reperfused STEMI.

Alessandro Bellis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.